Yezan Munther Haddadin, Director of Outlook Therapeutics OTLK, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $39K. The latest trade was on 06/02.

YH

YH

Yezan Munther Haddadin

Director

Company

Outlook Therapeutics OTLK

First filing

23/03/31

Trades

11 trades

Buys / sales

3 / 0

12-month net buying

$39K

Last trade

06/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Outlook TherapeuticsOTLK	Open-market buy	06/02	06/03	29,000 sh	$0.83	$24,070	+78.0%
Outlook TherapeuticsOTLK	Open-market buy	05/26	05/27	34,000 sh	$0.44	$14,960	+1073.6%
Outlook TherapeuticsOTLK	Open-market buy	24/03/28	24/03/29	1,881.71 sh	$11.82	$22,241.81	+59.4%